Innovative Biomaterials Advancing Medical Technology: 4D Medicine's Success
4D Medicine, a pioneering company situated in Nottingham, UK, is at the forefront of innovation in the field of biomaterials specifically designed for use in 3D printed implants and surgical devices. Recently, the company successfully raised an impressive $3.4 million in a Series A funding round, which was spearheaded by Oshen Holdings. The funding round garnered additional support from a variety of investors, including DSW Ventures, SFC Capital, Boundary Capital, as well as private investors that include scientists and surgeons deeply interested in advancing medical technology. This financial injection is poised to significantly propel the company's ongoing efforts in enhancing medical solutions through its advanced materials.
Under the astute leadership of CEO Philip Smith, 4D Medicine operates as a spin-out from the esteemed Universities of Birmingham and Warwick.
The company has made notable strides with the creation of 4Degra, a groundbreaking resorbable biomaterial tailored for the development of implants that cater to a multitude of medical needs. Among the applications for this innovative material are orthopaedic devices and soft tissue scaffolds, which play a crucial role in aiding patients during their recovery from surgical procedures or injuries. The implications of this technology are far-reaching, offering new hope to those who require advanced medical interventions to regain their health.
The current focus of 4D Medicine revolves around utilizing the newly acquired funds to complete the pre-clinical testing of its initial product line while simultaneously pursuing FDA clearance essential for entering the lucrative US market. Early tests involving the biomaterial have produced promising results, indicating that as the healing process unfolds, the material experiences gradual erosion, allowing it to be naturally resorbed by the body’s metabolic activities. This unique property ensures that as the patient's natural tissue regenerates, there is seamless integration, promoting effective healing and minimizing complications. 4D Medicine's journey is just beginning, and its advancements may very well redefine the landscape of medical implants in the near future.
They've invested in 4D Medicine
Get to know these Healthtech investors
Click here for a full list of 6,528+ startup investors in the UK